市場調査レポート

商品コード

1117526

世界の抗うつ剤市場：考察と予測 (2028年まで)

Global Antidepressants Market Insights, Forecast to 2028

出版日: 2022年08月22日 | 発行: QYResearch

| ページ情報: 英文 134 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 778,953円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,168,429円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,557,906円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、抗うつ剤 (Antidepressants) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

抗うつ剤の製品概要
市場：タイプ別
- 世界の抗うつ剤の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Tricyclic Antidepressants
- Selective Serotonin Reuptake Inhibitors
- Selective Norepinephrine Reuptake Inhibitors
- Monoamine Oxidase Inhibitors
- Benzodiazepines
- Antipsychotics
- Novel Agents
市場：アプリケーション別
- 世界の抗うつ剤の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Hospitals
- Clinics
- Other
調査目的
対象期間

第2章レポート概要

世界の抗うつ剤の販売推定および予測 2017-2028
世界の抗うつ剤の収益推定および予測 2017-2028
世界の抗うつ剤の収益：地域別: 2017 VS 2021 VS 2028
世界の抗うつ剤の販売：地域別
- 世界の抗うつ剤の販売：地域別 (2017-2022)
- 世界の販売抗うつ剤：地域別 (2023-2028)
世界の抗うつ剤の収益：地域別
- 世界の抗うつ剤の収益：地域別 (2017-2022)
- 世界の抗うつ剤の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界の抗うつ剤の販売：メーカー別
- 世界の抗うつ剤の上位メーカー：販売別 (2017-2022)
- 世界の抗うつ剤の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：抗うつ剤2021
世界の抗うつ剤の収益：メーカー別
- 世界の抗うつ剤の収益：メーカー別 (2017-2022)
- 世界の抗うつ剤の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：抗うつ剤の収益 2021
世界の抗うつ剤の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界の抗うつ剤の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界の抗うつ剤のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界の抗うつ剤の販売：タイプ別
- 世界の抗うつ剤の販売実績：タイプ別 (2017-2022)
- 世界の抗うつ剤の販売予測：タイプ別 (2023-2028)
- 世界の抗うつ剤の販売市場シェア：タイプ別 (2017-2028)
世界の抗うつ剤の収益：タイプ別
- 世界の抗うつ剤の収益実績：タイプ別 (2017-2022)
- 世界の抗うつ剤の収益予測：タイプ別 (2023-2028)
- 世界の抗うつ剤の収益市場シェア：タイプ別 (2017-2028)
世界の抗うつ剤の価格：タイプ別
- 世界の抗うつ剤の価格：タイプ別 (2017-2022)
- 世界の抗うつ剤の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界の抗うつ剤の販売：アプリケーション別
- 世界の抗うつ剤の販売実績：アプリケーション別 (2017-2022)
- 世界の抗うつ剤の販売予測：アプリケーション別 (2023-2028)
- 世界の抗うつ剤の販売市場シェア：アプリケーション別 (2017-2028)
世界の抗うつ剤の収益：アプリケーション別
- 世界の抗うつ剤の収益実績：アプリケーション別 (2017-2022)
- 世界の抗うつ剤の収益予測：アプリケーション別 (2023-2028)
- 世界の抗うつ剤の収益市場シェア：アプリケーション別 (2017-2028)
世界の抗うつ剤の価格：アプリケーション別
- 世界の抗うつ剤の価格：アプリケーション別 (2017-2022)
- 世界の抗うつ剤の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米の抗うつ剤市場規模：タイプ別
- 北米の抗うつ剤の販売：タイプ別 (2017-2028)
- 北米の抗うつ剤の収益：タイプ別 (2017-2028)
北米の抗うつ剤市場規模：アプリケーション別
- 北米の抗うつ剤の販売：アプリケーション別 (2017-2028)
- 北米の抗うつ剤の収益：アプリケーション別 (2017-2028)
北米の抗うつ剤市場規模：国別
- 北米の抗うつ剤の販売：国別 (2017-2028)
- 北米の抗うつ剤の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州の抗うつ剤市場規模：タイプ別
- 欧州の抗うつ剤の販売：タイプ別 (2017-2028)
- 欧州の抗うつ剤の収益：タイプ別 (2017-2028)
欧州の抗うつ剤市場規模：アプリケーション別
- 欧州の抗うつ剤の販売：アプリケーション別 (2017-2028)
- 欧州の抗うつ剤の収益：アプリケーション別 (2017-2028)
欧州の抗うつ剤市場規模：国別
- 欧州の抗うつ剤の販売：国別 (2017-2028)
- 欧州の抗うつ剤の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋の抗うつ剤市場規模：タイプ別
- アジア太平洋の抗うつ剤の販売：タイプ別 (2017-2028)
- アジア太平洋の抗うつ剤の収益：タイプ別 (2017-2028)
アジア太平洋の抗うつ剤市場規模：アプリケーション別
- アジア太平洋の抗うつ剤の販売：アプリケーション別 (2017-2028)
- アジア太平洋の抗うつ剤の収益：アプリケーション別 (2017-2028)
アジア太平洋の抗うつ剤市場規模：地域別
- アジア太平洋の抗うつ剤の販売：地域別 (2017-2028)
- アジア太平洋の抗うつ剤の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア
- フィリピン

第9章ラテンアメリカ

ラテンアメリカの抗うつ剤市場規模：タイプ別
- ラテンアメリカの抗うつ剤の販売：タイプ別 (2017-2028)
- ラテンアメリカの抗うつ剤の収益：タイプ別 (2017-2028)
ラテンアメリカの抗うつ剤市場規模：アプリケーション別
- ラテンアメリカの抗うつ剤の販売：アプリケーション別 (2017-2028)
- ラテンアメリカの抗うつ剤の収益：アプリケーション別 (2017-2028)
ラテンアメリカの抗うつ剤市場規模：国別
- ラテンアメリカの抗うつ剤の販売：国別 (2017-2028)
- ラテンアメリカの抗うつ剤の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン

第10章中東・アフリカ

中東・アフリカの抗うつ剤市場規模：タイプ別
- 中東・アフリカの抗うつ剤の販売：タイプ別 (2017-2028)
- 中東・アフリカの抗うつ剤の収益：タイプ別 (2017-2028)
中東・アフリカの抗うつ剤市場規模：アプリケーション別
- 中東・アフリカの抗うつ剤の販売：アプリケーション別 (2017-2028)
- 中東・アフリカの抗うつ剤の収益：アプリケーション別 (2017-2028)
中東・アフリカの抗うつ剤市場規模：国別
- 中東・アフリカの抗うつ剤の販売：国別 (2017-2028)
- 中東・アフリカの抗うつ剤の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi

第12章業界チェーンと販売チャネルの分析

抗うつ剤業界チェーン分析
抗うつ剤主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
抗うつ剤生産形態とプロセス
抗うつ剤販売およびマーケティング
- 抗うつ剤販売チャネル
- 抗うつ剤卸業者
抗うつ剤顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

抗うつ剤業界動向
抗うつ剤市場の促進要因
抗うつ剤市場の課題
抗うつ剤市場の抑制要因

第14章世界の抗うつ剤の主な市場調査結果

第15章付録

図表

Table 1. Global Antidepressants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tricyclic Antidepressants
Table 3. Major Manufacturers of Selective Serotonin Reuptake Inhibitors
Table 4. Major Manufacturers of Selective Norepinephrine Reuptake Inhibitors
Table 5. Major Manufacturers of Monoamine Oxidase Inhibitors
Table 6. Major Manufacturers of Benzodiazepines
Table 7. Major Manufacturers of Antipsychotics
Table 8. Major Manufacturers of Novel Agents
Table 9. Global Antidepressants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Antidepressants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Antidepressants Sales by Region (2017-2022) & (K Units)
Table 12. Global Antidepressants Sales Market Share by Region (2017-2022)
Table 13. Global Antidepressants Sales by Region (2023-2028) & (K Units)
Table 14. Global Antidepressants Sales Market Share by Region (2023-2028)
Table 15. Global Antidepressants Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Antidepressants Revenue Market Share by Region (2017-2022)
Table 17. Global Antidepressants Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Antidepressants Revenue Market Share by Region (2023-2028)
Table 19. Global Antidepressants Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Antidepressants Sales Share by Manufacturers (2017-2022)
Table 21. Global Antidepressants Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Antidepressants Revenue Share by Manufacturers (2017-2022)
Table 23. Antidepressants Price by Manufacturers (2017-2022) &(USD/Unit)
Table 24. Global Antidepressants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Antidepressants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidepressants as of 2021)
Table 26. Antidepressants Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Antidepressants Product Offered
Table 28. Date of Manufacturers Enter into Antidepressants Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Antidepressants Sales by Type (2017-2022) & (K Units)
Table 31. Global Antidepressants Sales by Type (2023-2028) & (K Units)
Table 32. Global Antidepressants Sales Share by Type (2017-2022)
Table 33. Global Antidepressants Sales Share by Type (2023-2028)
Table 34. Global Antidepressants Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Antidepressants Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Antidepressants Revenue Share by Type (2017-2022)
Table 37. Global Antidepressants Revenue Share by Type (2023-2028)
Table 38. Antidepressants Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Antidepressants Price Forecast by Type (2023-2028) & (USD/Unit)
Table 40. Global Antidepressants Sales by Application (2017-2022) & (K Units)
Table 41. Global Antidepressants Sales by Application (2023-2028) & (K Units)
Table 42. Global Antidepressants Sales Share by Application (2017-2022)
Table 43. Global Antidepressants Sales Share by Application (2023-2028)
Table 44. Global Antidepressants Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Antidepressants Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Antidepressants Revenue Share by Application (2017-2022)
Table 47. Global Antidepressants Revenue Share by Application (2023-2028)
Table 48. Antidepressants Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Antidepressants Price Forecast by Application (2023-2028) & (USD/Unit)
Table 50. North America Antidepressants Sales by Type (2017-2022) & (K Units)
Table 51. North America Antidepressants Sales by Type (2023-2028) & (K Units)
Table 52. North America Antidepressants Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Antidepressants Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Antidepressants Sales by Application (2017-2022) & (K Units)
Table 55. North America Antidepressants Sales by Application (2023-2028) & (K Units)
Table 56. North America Antidepressants Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Antidepressants Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Antidepressants Sales by Country (2017-2022) & (K Units)
Table 59. North America Antidepressants Sales by Country (2023-2028) & (K Units)
Table 60. North America Antidepressants Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Antidepressants Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Antidepressants Sales by Type (2017-2022) & (K Units)
Table 63. Europe Antidepressants Sales by Type (2023-2028) & (K Units)
Table 64. Europe Antidepressants Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Antidepressants Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Antidepressants Sales by Application (2017-2022) & (K Units)
Table 67. Europe Antidepressants Sales by Application (2023-2028) & (K Units)
Table 68. Europe Antidepressants Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Antidepressants Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Antidepressants Sales by Country (2017-2022) & (K Units)
Table 71. Europe Antidepressants Sales by Country (2023-2028) & (K Units)
Table 72. Europe Antidepressants Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Antidepressants Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Antidepressants Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Antidepressants Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Antidepressants Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Antidepressants Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Antidepressants Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Antidepressants Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Antidepressants Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Antidepressants Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Antidepressants Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Antidepressants Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Antidepressants Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Antidepressants Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Antidepressants Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Antidepressants Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Antidepressants Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Antidepressants Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Antidepressants Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Antidepressants Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Antidepressants Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Antidepressants Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Antidepressants Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Antidepressants Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Antidepressants Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Antidepressants Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Antidepressants Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Antidepressants Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Antidepressants Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Antidepressants Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Antidepressants Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Antidepressants Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Antidepressants Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Antidepressants Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Antidepressants Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Antidepressants Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Antidepressants Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Antidepressants Revenue by Country (2023-2028) & (US$ Million)
Table 110. H Lundbeck Corporation Information
Table 111. H Lundbeck Description and Major Businesses
Table 112. H Lundbeck Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. H Lundbeck Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. H Lundbeck Recent Developments
Table 115. Astrazeneca Corporation Information
Table 116. Astrazeneca Description and Major Businesses
Table 117. Astrazeneca Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Astrazeneca Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Astrazeneca Recent Developments
Table 120. Eli Lilly and Company Corporation Information
Table 121. Eli Lilly and Company Description and Major Businesses
Table 122. Eli Lilly and Company Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Eli Lilly and Company Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lilly and Company Recent Developments
Table 125. Sun Pharmaceuticals Corporation Information
Table 126. Sun Pharmaceuticals Description and Major Businesses
Table 127. Sun Pharmaceuticals Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Sun Pharmaceuticals Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sun Pharmaceuticals Recent Developments
Table 130. Pfizer Inc. Corporation Information
Table 131. Pfizer Inc. Description and Major Businesses
Table 132. Pfizer Inc. Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Pfizer Inc. Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Pfizer Inc. Recent Developments
Table 135. GlaxoSmithKline Corporation Information
Table 136. GlaxoSmithKline Description and Major Businesses
Table 137. GlaxoSmithKline Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. GlaxoSmithKline Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. GlaxoSmithKline Recent Developments
Table 140. Bristol-Myers Squibb Company Corporation Information
Table 141. Bristol-Myers Squibb Company Description and Major Businesses
Table 142. Bristol-Myers Squibb Company Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Bristol-Myers Squibb Company Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Bristol-Myers Squibb Company Recent Developments
Table 145. Johnson & Johnson Corporation Information
Table 146. Johnson & Johnson Description and Major Businesses
Table 147. Johnson & Johnson Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Johnson & Johnson Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Johnson & Johnson Recent Developments
Table 150. Merck Corporation Information
Table 151. Merck Description and Major Businesses
Table 152. Merck Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Merck Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Merck Recent Developments
Table 155. Sanofi Corporation Information
Table 156. Sanofi Description and Major Businesses
Table 157. Sanofi Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Sanofi Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Sanofi Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Antidepressants Distributors List
Table 163. Antidepressants Customers List
Table 164. Antidepressants Market Trends
Table 165. Antidepressants Market Drivers
Table 166. Antidepressants Market Challenges
Table 167. Antidepressants Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Antidepressants Product Picture
Figure 3. Global Antidepressants Market Share by Type in 2021 & 2028
Figure 3. Tricyclic Antidepressants Product Picture
Figure 4. Selective Serotonin Reuptake Inhibitors Product Picture
Figure 5. Selective Norepinephrine Reuptake Inhibitors Product Picture
Figure 6. Monoamine Oxidase Inhibitors Product Picture
Figure 7. Benzodiazepines Product Picture
Figure 8. Antipsychotics Product Picture
Figure 9. Novel Agents Product Picture
Figure 10. Global Antidepressants Market Share by Application in 2021 & 2028
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Other
Figure 14. Antidepressants Report Years Considered
Figure 15. Global Antidepressants Sales 2017-2028 (K Units)
Figure 16. Global Antidepressants Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Antidepressants Revenue 2017-2028 (US$ Million)
Figure 18. Global Antidepressants Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Antidepressants Sales Market Share by Region (2017-2022)
Figure 20. Global Antidepressants Sales Market Share by Region (2023-2028)
Figure 21. North America Antidepressants Sales YoY (2017-2028) & (K Units)
Figure 22. North America Antidepressants Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Antidepressants Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Antidepressants Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Antidepressants Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Antidepressants Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Antidepressants Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Antidepressants Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Antidepressants Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Antidepressants Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Antidepressants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Antidepressants in the World: Market Share by Antidepressants Revenue in 2021
Figure 33. Global Antidepressants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Antidepressants Sales Market Share by Type (2017-2028)
Figure 35. Global Antidepressants Revenue Market Share by Type (2017-2028)
Figure 36. Global Antidepressants Sales Market Share by Application (2017-2028)
Figure 37. Global Antidepressants Revenue Market Share by Application (2017-2028)
Figure 38. North America Antidepressants Sales Market Share by Type (2017-2028)
Figure 39. North America Antidepressants Revenue Market Share by Type (2017-2028)
Figure 40. North America Antidepressants Sales Market Share by Application (2017-2028)
Figure 41. North America Antidepressants Revenue Market Share by Application (2017-2028)
Figure 42. North America Antidepressants Sales Share by Country (2017-2028)
Figure 43. North America Antidepressants Revenue Share by Country (2017-2028)
Figure 44. U.S. Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Antidepressants Sales Market Share by Type (2017-2028)
Figure 47. Europe Antidepressants Revenue Market Share by Type (2017-2028)
Figure 48. Europe Antidepressants Sales Market Share by Application (2017-2028)
Figure 49. Europe Antidepressants Revenue Market Share by Application (2017-2028)
Figure 50. Europe Antidepressants Sales Share by Country (2017-2028)
Figure 51. Europe Antidepressants Revenue Share by Country (2017-2028)
Figure 52. Germany Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 53. France Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Antidepressants Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Antidepressants Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Antidepressants Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Antidepressants Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Antidepressants Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Antidepressants Revenue Share by Region (2017-2028)
Figure 63. China Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 66. India Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Antidepressants Sales Market Share by Type (2017-2028)
Figure 74. Latin America Antidepressants Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Antidepressants Sales Market Share by Application (2017-2028)
Figure 76. Latin America Antidepressants Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Antidepressants Sales Share by Country (2017-2028)
Figure 78. Latin America Antidepressants Revenue Share by Country (2017-2028)
Figure 79. Mexico Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Antidepressants Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Antidepressants Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Antidepressants Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Antidepressants Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Antidepressants Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Antidepressants Revenue Share by Country (2017-2028)
Figure 88. Turkey Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Antidepressants Revenue (2017-2028) & (US$ Million)
Figure 91. Antidepressants Value Chain
Figure 92. Antidepressants Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

This research report focuses on the Antidepressants Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Antidepressants Product Introduction
1.2 Market by Type
- 1.2.1 Global Antidepressants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Tricyclic Antidepressants
- 1.2.3 Selective Serotonin Reuptake Inhibitors
- 1.2.4 Selective Norepinephrine Reuptake Inhibitors
- 1.2.5 Monoamine Oxidase Inhibitors
- 1.2.6 Benzodiazepines
- 1.2.7 Antipsychotics
- 1.2.8 Novel Agents
1.3 Market by Application
- 1.3.1 Global Antidepressants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Antidepressants Sales Estimates and Forecasts 2017-2028
2.2 Global Antidepressants Revenue Estimates and Forecasts 2017-2028
2.3 Global Antidepressants Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antidepressants Sales by Region
- 2.4.1 Global Antidepressants Sales by Region (2017-2022)
- 2.4.2 Global Sales Antidepressants by Region (2023-2028)
2.5 Global Antidepressants Revenue by Region
- 2.5.1 Global Antidepressants Revenue by Region (2017-2022)
- 2.5.2 Global Antidepressants Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Antidepressants Sales by Manufacturers
- 3.1.1 Global Top Antidepressants Manufacturers by Sales (2017-2022)
- 3.1.2 Global Antidepressants Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antidepressants in 2021
3.2 Global Antidepressants Revenue by Manufacturers
- 3.2.1 Global Antidepressants Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Antidepressants Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Antidepressants Revenue in 2021
3.3 Global Antidepressants Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Antidepressants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Antidepressants Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Antidepressants Sales by Type
- 4.1.1 Global Antidepressants Historical Sales by Type (2017-2022)
- 4.1.2 Global Antidepressants Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Antidepressants Sales Market Share by Type (2017-2028)
4.2 Global Antidepressants Revenue by Type
- 4.2.1 Global Antidepressants Historical Revenue by Type (2017-2022)
- 4.2.2 Global Antidepressants Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Antidepressants Revenue Market Share by Type (2017-2028)
4.3 Global Antidepressants Price by Type
- 4.3.1 Global Antidepressants Price by Type (2017-2022)
- 4.3.2 Global Antidepressants Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Antidepressants Sales by Application
- 5.1.1 Global Antidepressants Historical Sales by Application (2017-2022)
- 5.1.2 Global Antidepressants Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Antidepressants Sales Market Share by Application (2017-2028)
5.2 Global Antidepressants Revenue by Application
- 5.2.1 Global Antidepressants Historical Revenue by Application (2017-2022)
- 5.2.2 Global Antidepressants Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Antidepressants Revenue Market Share by Application (2017-2028)
5.3 Global Antidepressants Price by Application
- 5.3.1 Global Antidepressants Price by Application (2017-2022)
- 5.3.2 Global Antidepressants Price Forecast by Application (2023-2028)

6 North America

6.1 North America Antidepressants Market Size by Type
- 6.1.1 North America Antidepressants Sales by Type (2017-2028)
- 6.1.2 North America Antidepressants Revenue by Type (2017-2028)
6.2 North America Antidepressants Market Size by Application
- 6.2.1 North America Antidepressants Sales by Application (2017-2028)
- 6.2.2 North America Antidepressants Revenue by Application (2017-2028)
6.3 North America Antidepressants Market Size by Country
- 6.3.1 North America Antidepressants Sales by Country (2017-2028)
- 6.3.2 North America Antidepressants Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada

7 Europe

7.1 Europe Antidepressants Market Size by Type
- 7.1.1 Europe Antidepressants Sales by Type (2017-2028)
- 7.1.2 Europe Antidepressants Revenue by Type (2017-2028)
7.2 Europe Antidepressants Market Size by Application
- 7.2.1 Europe Antidepressants Sales by Application (2017-2028)
- 7.2.2 Europe Antidepressants Revenue by Application (2017-2028)
7.3 Europe Antidepressants Market Size by Country
- 7.3.1 Europe Antidepressants Sales by Country (2017-2028)
- 7.3.2 Europe Antidepressants Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Antidepressants Market Size by Type
- 8.1.1 Asia Pacific Antidepressants Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Antidepressants Revenue by Type (2017-2028)
8.2 Asia Pacific Antidepressants Market Size by Application
- 8.2.1 Asia Pacific Antidepressants Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Antidepressants Revenue by Application (2017-2028)
8.3 Asia Pacific Antidepressants Market Size by Region
- 8.3.1 Asia Pacific Antidepressants Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Antidepressants Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines

9 Latin America

9.1 Latin America Antidepressants Market Size by Type
- 9.1.1 Latin America Antidepressants Sales by Type (2017-2028)
- 9.1.2 Latin America Antidepressants Revenue by Type (2017-2028)
9.2 Latin America Antidepressants Market Size by Application
- 9.2.1 Latin America Antidepressants Sales by Application (2017-2028)
- 9.2.2 Latin America Antidepressants Revenue by Application (2017-2028)
9.3 Latin America Antidepressants Market Size by Country
- 9.3.1 Latin America Antidepressants Sales by Country (2017-2028)
- 9.3.2 Latin America Antidepressants Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Antidepressants Market Size by Type
- 10.1.1 Middle East and Africa Antidepressants Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Antidepressants Revenue by Type (2017-2028)
10.2 Middle East and Africa Antidepressants Market Size by Application
- 10.2.1 Middle East and Africa Antidepressants Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Antidepressants Revenue by Application (2017-2028)
10.3 Middle East and Africa Antidepressants Market Size by Country
- 10.3.1 Middle East and Africa Antidepressants Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Antidepressants Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 H Lundbeck
- 11.1.1 H Lundbeck Corporation Information
- 11.1.2 H Lundbeck Overview
- 11.1.3 H Lundbeck Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 H Lundbeck Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 H Lundbeck Recent Developments
11.2 Astrazeneca
- 11.2.1 Astrazeneca Corporation Information
- 11.2.2 Astrazeneca Overview
- 11.2.3 Astrazeneca Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Astrazeneca Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Astrazeneca Recent Developments
11.3 Eli Lilly and Company
- 11.3.1 Eli Lilly and Company Corporation Information
- 11.3.2 Eli Lilly and Company Overview
- 11.3.3 Eli Lilly and Company Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Eli Lilly and Company Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Eli Lilly and Company Recent Developments
11.4 Sun Pharmaceuticals
- 11.4.1 Sun Pharmaceuticals Corporation Information
- 11.4.2 Sun Pharmaceuticals Overview
- 11.4.3 Sun Pharmaceuticals Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Sun Pharmaceuticals Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Sun Pharmaceuticals Recent Developments
11.5 Pfizer Inc.
- 11.5.1 Pfizer Inc. Corporation Information
- 11.5.2 Pfizer Inc. Overview
- 11.5.3 Pfizer Inc. Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Pfizer Inc. Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Pfizer Inc. Recent Developments
11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Corporation Information
- 11.6.2 GlaxoSmithKline Overview
- 11.6.3 GlaxoSmithKline Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 GlaxoSmithKline Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 GlaxoSmithKline Recent Developments
11.7 Bristol-Myers Squibb Company
- 11.7.1 Bristol-Myers Squibb Company Corporation Information
- 11.7.2 Bristol-Myers Squibb Company Overview
- 11.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Bristol-Myers Squibb Company Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Bristol-Myers Squibb Company Recent Developments
11.8 Johnson & Johnson
- 11.8.1 Johnson & Johnson Corporation Information
- 11.8.2 Johnson & Johnson Overview
- 11.8.3 Johnson & Johnson Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Johnson & Johnson Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Johnson & Johnson Recent Developments
11.9 Merck
- 11.9.1 Merck Corporation Information
- 11.9.2 Merck Overview
- 11.9.3 Merck Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Merck Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Merck Recent Developments
11.10 Sanofi
- 11.10.1 Sanofi Corporation Information
- 11.10.2 Sanofi Overview
- 11.10.3 Sanofi Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 Sanofi Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Sanofi Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Antidepressants Industry Chain Analysis
12.2 Antidepressants Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Antidepressants Production Mode & Process
12.4 Antidepressants Sales and Marketing
- 12.4.1 Antidepressants Sales Channels
- 12.4.2 Antidepressants Distributors
12.5 Antidepressants Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Antidepressants Industry Trends
13.2 Antidepressants Market Drivers
13.3 Antidepressants Market Challenges
13.4 Antidepressants Market Restraints

14 Key Findings in The Global Antidepressants Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

世界の抗うつ剤市場：考察と予測 (2028年まで)

Global Antidepressants Market Insights, Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の抗うつ剤の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Antidepressants Study

15 Appendix

世界の抗うつ剤市場：考察と予測 (2028年まで)

Global Antidepressants Market Insights, Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界の抗うつ剤の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Antidepressants Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の抗うつ剤の主な市場調査結果

第15章付録